RevitalVision announced its U.S. market entry with a portfolio of digital training therapies clinically proven to improve vision in conditions, such as adult amblyopia, keratoconus, nystagmus, and early presbyopia. Its programs have been available in Europe since 2022.

According to the company, the technology offers eyecare professionals (ECPs) an effective tool to improve patients’ vision by utilizing a proprietary algorithm to visually stimulate the brain’s visual cortex. The prescribed, home-based, vision training software operates directly from a standard web browser on any personal computer without the need for any special hardware. 

RevitalVision has partnered with Launchpad Vision to introduce the technology across seven key US regions, including in nearly 20 pilot practices. As part of RevitalVision’s US infrastructure build-out, Charles Morris has been appointed as general manager, North America. Most recently, Morris held roles as global brand director for CooperVision’s specialty eyecare portfolio and director of marketing for Paragon Vision Sciences.